This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: Apple, Facebook, Twitter

Bed Bath & Beyond (BBBY) numbers were cut at J.P. Morgan. Twelve-month price target is now $75. Estimates were also reduced, given margin pressure, J.P. Morgan said. Neutral rating.

Bed Bath & Beyond 12-month price target was cut at Barclays to $80. Lower-than-expected fourth-quarter numbers and ongoing deterioation of gross margins, Barclays said.

Charles River Laboratories (CRL) 12-month price target was increased to $73 at Jefferies. Earnings estimates were also increased. Outsourced R&D spending is expected to grow with biotech funding contributing, Jefferies said. Buy rating.

Covance (CVD) 12-month price target was raised to $117 at Jefferies. Driven by exposure to biotech and early development, Jefferies said. Buy rating.

Delphi (DLPH) 12-month price target was raised at Barclays to $82. Driven by exposure to secular growth and margin moats, Barclays said.

MSC Industrial Direct (MSM) 12-month price target was increased at UBS to $93. Beat on margins despite weather and improving operating improvement, UBS said. Neutral rating.

Constellation Brands (STZ) numbers were boosted at Societe Generale. Twelve-month price target is now $77. Estimates were also increased, given higher growth in the beer business, Societe Generale said. Sell rating.

Follow TheStreet on Twitter and become a fan on Facebook

This article was written by a staff member of TheStreet.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $125.80 0.00%
FB $77.56 0.00%
GOOG $530.80 0.00%
TSLA $232.95 0.00%
YHOO $41.30 0.00%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs